| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10741-018-9753-5 |
| P698 | PubMed publication ID | 30535839 |
| P50 | author | Jinhui Wang | Q90395125 |
| P2093 | author name string | Weijian Zhou | |
| Xiaoning Yin | |||
| P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association | Q30238784 | ||
| Understanding the Epidemiology of Heart Failure to Improve Management Practices: An Asia-Pacific Perspective. | Q30238890 | ||
| Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial | Q34003169 | ||
| Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis | Q35075197 | ||
| Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. | Q36073064 | ||
| Targeting Hyponatremia and Hemodynamics in Acute Decompensated Heart Failure: Is There a Role for Vasopressin Antagonists? | Q37806693 | ||
| Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry). | Q38642417 | ||
| Acute decompensated heart failure (ADHF): A comprehensive contemporary review on preventing early readmissions and postdischarge death | Q38824627 | ||
| Tolvaptan for Heart Failure, Systematic Review and Meta-Analysis of Trials. | Q38829695 | ||
| Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload | Q39158288 | ||
| Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan | Q39225978 | ||
| Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure | Q39885691 | ||
| Prognostic Significance of Discharge Hyponatremia in Heart Failure Patients With Normal Admission Sodium (from the ESCAPE Trial). | Q40137907 | ||
| Clinical profile, management, and mortality in very-elderly patients hospitalized with acute decompensated heart failure: An analysis from the ATTEND registry | Q40517406 | ||
| Recovery from hyponatremia in acute phase is associated with better in-hospital mortality rate in acute heart failure syndrome | Q40857193 | ||
| Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial | Q44878889 | ||
| Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME- | Q46468937 | ||
| Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis | Q46682108 | ||
| Hyponatraemia and its prognosis in acute heart failure is related to right ventricular dysfunction | Q50100366 | ||
| Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation | Q51888144 | ||
| Improvement of hyponatraemia during hospitalisation for acute heart failure is not associated with improvement of prognosis: an analysis from the Korean Heart Failure (KorHF) registry | Q57224616 | ||
| Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial | Q57413975 | ||
| Characterization and Prognostic Value of Persistent Hyponatremia in Patients With Severe Heart Failure in the ESCAPE Trial | Q57630871 | ||
| Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry | Q57630914 | ||
| Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure | Q70174310 | ||
| Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia | Q70309996 | ||
| Hyponatremia in congestive heart failure: implications for neurohumoral activation and responses to orthostasis | Q70382366 | ||
| Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction | Q83232635 | ||
| Impact of Change in Serum Sodium Concentration on Mortality in Patients Hospitalized With Heart Failure and Hyponatremia | Q84360782 | ||
| P433 | issue | 2 | |
| P921 | main subject | hyponatremia | Q824292 |
| acute decompensated heart failure | Q4677930 | ||
| P304 | page(s) | 209-217 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | Heart Failure Reviews | Q2167497 |
| P1476 | title | Improvement of hyponatremia is associated with lower mortality risk in patients with acute decompensated heart failure: a meta-analysis of cohort studies | |
| P478 | volume | 24 |
| Q91867332 | Impact of Vaptans on Clinical Outcomes in Cirrhosis Patients: A Meta-Analysis of Randomized Controlled Trials | cites work | P2860 |
Search more.